The CRISPR pioneer Feng Zhang is launching yet another ambitious gene-editing startup, backed by approximately $200 million from some of biotech's biggest investors. The Cambridge, Massachusetts ...
Maya Ajmera, President & CEO of Society for Science & the Public and Publisher of Science News, chatted with Feng Zhang, a Core Institute Member of the Broad Institute, a Professor at MIT ...
Within the human digestive tract are trillions of bacteria from thousands of different species. These bacteria form ...
The technology at the heart of that discovery is what’s known as Crispr, and Zhang is one of the scientists who pioneered its use in human cells, sparking a flurry of interest in using Crispr to ...
healthy microbial community," says An-Ni Zhang, a former MIT postdoc who is now an assistant professor at Nanyang Technological University. In bacteria, CRISPR serves as a memory immune response.